These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 6298467)
1. Sendai virus envelopes can mediate Epstein-Barr virus binding to and penetration into Epstein-Barr virus receptor-negative cells. Khélifa R; Menezes J J Virol; 1983 Apr; 46(1):325-32. PubMed ID: 6298467 [TBL] [Abstract][Full Text] [Related]
2. Use of virus-attached antibodies or insulin molecules to mediate fusion between Sendai virus envelopes and neuraminidase-treated cells. Gitman AG; Kahane I; Loyter A Biochemistry; 1985 May; 24(11):2762-8. PubMed ID: 2992575 [TBL] [Abstract][Full Text] [Related]
3. Use of fluoresceinated Epstein-Barr virus to study Epstein-Barr virus-lymphoid cell interactions. Khelifa R; Menezes J J Virol; 1982 Feb; 41(2):649-56. PubMed ID: 6281475 [TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus-lymphoid cell interactions. III. Effect of concanavalin A and saccharides on Epstein-Barr virus penetration. Khélifa R; Menezes J J Virol; 1982 May; 42(2):402-10. PubMed ID: 6283164 [TBL] [Abstract][Full Text] [Related]
6. Transfer of Epstein-Barr virus receptors to receptor-negative cells permits virus penetration and antigen expression. Volsky DJ; Shapiro IM; Klein G Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5453-7. PubMed ID: 6254082 [TBL] [Abstract][Full Text] [Related]
7. Differences in Epstein-Barr virus (EBV) receptors expression on various human lymphoid targets and their significance to EBV-cell interaction. Stocco R; Sauvageau G; Menezes J Virus Res; 1988 Oct; 11(3):209-25. PubMed ID: 2848382 [TBL] [Abstract][Full Text] [Related]
8. Expression of Epstein-Barr virus (EBV) DNA and cloned DNA fragments in human lymphocytes following Sendai virus envelope-mediated gene transfer. Volsky DJ; Gross T; Sinangil F; Kuszynski C; Bartzatt R; Dambaugh T; Kieff E Proc Natl Acad Sci U S A; 1984 Oct; 81(19):5926-30. PubMed ID: 6091119 [TBL] [Abstract][Full Text] [Related]
9. The use of specific antibodies to mediate fusion between Sendai virus envelopes and living cells. Loyter A; Tomasi M; Gitman AG; Etinger L; Nussbaum O Ciba Found Symp; 1984; 103():163-80. PubMed ID: 6323106 [TBL] [Abstract][Full Text] [Related]
10. Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d. Nemerow GR; Mold C; Schwend VK; Tollefson V; Cooper NR J Virol; 1987 May; 61(5):1416-20. PubMed ID: 3033269 [TBL] [Abstract][Full Text] [Related]
11. Incorporation of the purified Epstein Barr virus/C3d receptor (CR2) into liposomes and demonstration of its dual ligand binding functions. Mold C; Cooper NR; Nemerow GR J Immunol; 1986 Jun; 136(11):4140-5. PubMed ID: 3009615 [TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus receptor expression on human CD8+ (cytotoxic/suppressor) T lymphocytes. Sauvageau G; Stocco R; Kasparian S; Menezes J J Gen Virol; 1990 Feb; 71 ( Pt 2)():379-86. PubMed ID: 2155291 [TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr Virus and its glycoprotein-350 upregulate IL-6 in human B-lymphocytes via CD21, involving activation of NF-kappaB and different signaling pathways. D'Addario M; Libermann TA; Xu J; Ahmad A; Menezes J J Mol Biol; 2001 May; 308(3):501-14. PubMed ID: 11327783 [TBL] [Abstract][Full Text] [Related]
14. Epstein Barr virus binding induces internalization of the C3d receptor: a novel immunotoxin delivery system. Tedder TF; Goldmacher VS; Lambert JM; Schlossman SF J Immunol; 1986 Aug; 137(4):1387-91. PubMed ID: 3016095 [TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus-induced increase in the concanavalin-A receptor density of established EBV-negative lymphoma lines in vitro. Siegert W; Mönch T; Valet G Exp Hematol; 1980 Nov; 8(10):1173-82. PubMed ID: 6262102 [TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus infection of human gastric carcinoma cells: implication of the existence of a new virus receptor different from CD21. Yoshiyama H; Imai S; Shimizu N; Takada K J Virol; 1997 Jul; 71(7):5688-91. PubMed ID: 9188650 [TBL] [Abstract][Full Text] [Related]
17. Fusion of Sendai virions or reconstituted Sendai virus envelopes with liposomes or erythrocyte membranes lacking virus receptors. Citovsky V; Loyter A J Biol Chem; 1985 Oct; 260(22):12072-7. PubMed ID: 2995357 [TBL] [Abstract][Full Text] [Related]
18. Active function of membrane receptors for enveloped viruses. I. Specific requirement for liposome-associated sialoglycolipids, but not sialoglycoproteins, to allow lysis of phospholipid vesicles by reconstituted Sendai viral envelopes. Citovsky V; Zakai N; Loyter A Exp Cell Res; 1986 Oct; 166(2):279-94. PubMed ID: 3017741 [TBL] [Abstract][Full Text] [Related]
19. Expression of the Epstein-Barr virus (EBV) receptor on the surface of cells infected with EBV derived from nasopharyngeal carcinoma. Takimoto T; Umeda R Acta Virol; 1989 Aug; 33(4):314-9. PubMed ID: 2574937 [TBL] [Abstract][Full Text] [Related]
20. Superinfection of epithelial hybrid cells (D98/HR-1, NPC-KT, and A2L/AH) with Epstein-Barr virus and the relationship to the C3d receptor. Takimoto T; Sato H; Ogura H; Miyawaki T; Glaser R Cancer Res; 1986 May; 46(5):2541-4. PubMed ID: 3008992 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]